This company listing is no longer active
PHC Stock Overview
Provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Plant Health Care plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.089 |
| 52 Week High | UK£0.10 |
| 52 Week Low | UK£0.032 |
| Beta | 0.81 |
| 11 Month Change | 1.42% |
| 3 Month Change | 40.00% |
| 1 Year Change | -4.03% |
| 33 Year Change | -31.87% |
| 5 Year Change | 13.33% |
| Change since IPO | -84.20% |
Recent News & Updates
Recent updates
Plant Health Care plc's (LON:PHC) P/S Is Still On The Mark Following 76% Share Price Bounce
Jun 05
One Analyst Just Shaved Their Plant Health Care plc (LON:PHC) Forecasts Dramatically
Nov 23Plant Health Care plc's (LON:PHC) Share Price Matching Investor Opinion
Sep 28Would Shareholders Who Purchased Plant Health Care's (LON:PHC) Stock Five Years Be Happy With The Share price Today?
Feb 10
Shareholder Returns
| PHC | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0.3% | 1.0% | -0.8% |
| 1Y | -4.0% | -14.4% | 7.9% |
Return vs Industry: PHC exceeded the UK Chemicals industry which returned -26.2% over the past year.
Return vs Market: PHC underperformed the UK Market which returned 11.8% over the past year.
Price Volatility
| PHC volatility | |
|---|---|
| PHC Average Weekly Movement | 15.6% |
| Chemicals Industry Average Movement | 6.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.0% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PHC's share price has been volatile over the past 3 months.
Volatility Over Time: PHC's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 55 | Jeff Tweedy | www.planthealthcare.com |
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil. It operates through Commercial – Americas; Commercial – Mexico; Commercial – Rest of World; and Plant Response Elicitor Technology (PREtec) segments. The company offers Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the quality, nutrient use, tolerance to abiotic stress, and yield quality of crops; Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease; and Obrana, a foliar product to help growers control a range of fungal and bacterial plant pathogens within fruits, nuts, vegetables, and row crops.
Plant Health Care plc Fundamentals Summary
| PHC fundamental statistics | |
|---|---|
| Market cap | UK£30.48m |
| Earnings (TTM) | -UK£3.07m |
| Revenue (TTM) | UK£8.59m |
3.5x
P/S Ratio-9.9x
P/E RatioIs PHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHC income statement (TTM) | |
|---|---|
| Revenue | US$11.21m |
| Cost of Revenue | US$4.44m |
| Gross Profit | US$6.77m |
| Other Expenses | US$10.77m |
| Earnings | -US$4.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 60.37% |
| Net Profit Margin | -35.70% |
| Debt/Equity Ratio | 4.7% |
How did PHC perform over the long term?
See historical performance and comparison